XXI Wealth’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
XXI Wealth's NVS Position: Q3 2026 in Review
XXI Wealth reduced its Novartis (NVS) stake by 13% in Q3 2026, selling an estimated $58.2K and leaving 2,598 shares worth $370K. The position accounts for 0.15% of the portfolio, ranked #156.
XXI Wealth first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $467K in Q2 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- XXI Wealth held 2,598 shares of Novartis worth $370K as of Q3 2026.
- XXI Wealth sold 384 Novartis shares in Q3 2026, an estimated $58.2K.
- Novartis made up 0.15% of XXI Wealth's portfolio in Q3 2026, its #156 holding.
- XXI Wealth first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
- XXI Wealth's Novartis position peaked at $467K in Q2 2026.
- 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.